...
首页> 外文期刊>Intensive care medicine >Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.
【24h】

Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.

机译:舒芬太尼/异丙酚和舒芬太尼/咪达唑仑退出治疗。外科ICU患者的镇静作用:与中枢神经参数和内源性阿片类药物的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Patients in the ICU after long-term administration of an opioid/hypnotic often develop delirium. To assess the nature of this phenomenon, patients in a surgical ICU following ventilatory support and sedation with an opioid/hypnotic/sedative were studied. METHODOLOGY: Following sufentanil/midazolam (group 1; n =14) or sufentanil/propofol (group 2; n =15) sedation, patients were evaluated for changes in mean arterial blood pressure and heart rate, the activity of the central nervous system (sensory evoked potentials, spectral edge frequency of EEG), and the endogenous opioids plasma concentrations (beta-endorphin, met-enkephalin). Data obtained were correlated with the individual intensities of withdrawal symptoms 6-, 12-, and 24 h following sedation. RESULTS: Following a mean duration of ventilation of 7.7 days (+/-3.6 SD) in groups 1 and 3.5 (+/-1.7 SD) in group 2, withdrawal intensities peaked within the 6th hour after cessation. Plasma beta-endorphin and met-enkephalin levels were low duringsedation, and only the sufentanil/midazolam group demonstrated a postinhibitory overshoot. Withdrawal symptom intensities demonstrated an inverse correlation with beta-endorphin and met-enkephalin levels, a direct linear correlation with amplitude height of the evoked potential, and blood pressure and heart rate changes. Withdrawal intensities did not correlate with EEG power spectral edge frequency. CONCLUSION: The endorphinergic system is suppressed when a potent exogenous opioid like sufentanil is given over a long period of time. Following sedation, abstinence symptoms seem to be related to postinhibitory increased endorphin synthesis. This is mostly seen in the combination of sufentanil/midazolam. In addition, an increase in the amplitude of the sensory-evoked potential suggests a postinhibitory excitatory state within the nociceptive system.
机译:目的:长期服用阿片类药物/催眠药后在ICU中的患者经常会出现often妄。为了评估这种现象的性质,研究了在外科ICU中接受了阿片类药物/催眠药/镇静剂的通气支持和镇静作用的患者。方法:在使用舒芬太尼/咪达唑仑(第1组; n = 14)或舒芬太尼/丙泊酚(第2组; n = 15)镇静后,评估患者的平均动脉血压和心率,中枢神经系统活动(感觉诱发电位,脑电图的频谱边缘频率)和内源性阿片类药物血浆浓度(β-内啡肽,甲脑啡肽)。镇静后6、12和24小时,所获得的数据与戒断症状的个体强度相关。结果:第1组平均通气时间为7.7天(+/- 3.6 SD),第2组平均通气时间为3.5(+/- 1.7 SD),戒断强度在戒断后第6小时达到峰值。镇静过程中血浆β-内啡肽和甲脑啡肽水平较低,只有舒芬太尼/咪达唑仑组表现出抑制后超调。戒断症状强度与β-内啡肽和甲脑啡肽水平呈负相关,与诱发电位的幅度高度,血压和心率变化呈线性相关。戒断强度与脑电功率谱边缘频率无关。结论:长时间服用有效的外源性阿片样物质如舒芬太尼后,内啡肽能系统受到抑制。镇静后,节制症状似乎与抑制后内啡肽合成增加有关。这主要在舒芬太尼/咪达唑仑的组合中看到。另外,感觉诱发电位的幅度增加表明在伤害感受系统内具有抑制后的兴奋状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号